Tuncel M et al. |
The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. |
2007 |
Cancer Biother. Radiopharm. |
pmid:17600477
|
Tuncel M et al. |
The comparative effects of gene modulators on thyroid-specific genes and radioiodine uptake. |
2007 |
Cancer Biother. Radiopharm. |
pmid:17679169
|
Cao QF et al. |
TRPM2 mediates histone deacetylase inhibition-induced apoptosis in bladder cancer cells. |
2015 |
Cancer Biother. Radiopharm. |
pmid:25760728
|
Yamashita K et al. |
Pharmacologic unmasking of epigenetically silenced tumor suppressor genes in esophageal squamous cell carcinoma. |
2002 |
Cancer Cell |
pmid:12498717
|
Gius D et al. |
Distinct effects on gene expression of chemical and genetic manipulation of the cancer epigenome revealed by a multimodality approach. |
2004 |
Cancer Cell |
pmid:15488759
|
Maecker HL et al. |
Epigenetic changes in tumor Fas levels determine immune escape and response to therapy. |
2002 |
Cancer Cell |
pmid:12204534
|
Jiang X et al. |
DACT3 is an epigenetic regulator of Wnt/beta-catenin signaling in colorectal cancer and is a therapeutic target of histone modifications. |
2008 |
Cancer Cell |
pmid:18538736
|
Brugarolas JB et al. |
TSC2 regulates VEGF through mTOR-dependent and -independent pathways. |
2003 |
Cancer Cell |
pmid:12957289
|
Yoshida M et al. |
Histone deacetylase as a new target for cancer chemotherapy. |
2001 |
Cancer Chemother. Pharmacol. |
pmid:11587361
|
Bovenzi V and Momparler RL |
Antineoplastic action of 5-aza-2'-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor beta and estrogen receptor alpha genes in breast carcinoma cells. |
2001 |
Cancer Chemother. Pharmacol. |
pmid:11488527
|
Whang YM et al. |
Hyperacetylation enhances the growth-inhibitory effect of all-trans retinoic acid by the restoration of retinoic acid receptor beta expression in head and neck squamous carcinoma (HNSCC) cells. |
2005 |
Cancer Chemother. Pharmacol. |
pmid:15959780
|
Kang J et al. |
Synergistic killing of human leukemia cells by antioxidants and trichostatin A. |
2004 |
Cancer Chemother. Pharmacol. |
pmid:15248029
|
Fandy TE and Srivastava RK |
Trichostatin A sensitizes TRAIL-resistant myeloma cells by downregulation of the antiapoptotic Bcl-2 proteins. |
2006 |
Cancer Chemother. Pharmacol. |
pmid:16435155
|
Wunder T et al. |
Expression of the coxsackie adenovirus receptor in neuroendocrine lung cancers and its implications for oncolytic adenoviral infection. |
2013 |
Cancer Gene Ther. |
pmid:23196273
|
El-Zawahry A et al. |
In vitro efficacy of AdTRAIL gene therapy of bladder cancer is enhanced by trichostatin A-mediated restoration of CAR expression and downregulation of cFLIP and Bcl-XL. |
2006 |
Cancer Gene Ther. |
pmid:16167063
|
Katsura T et al. |
The effects of trichostatin A on the oncolytic ability of herpes simplex virus for oral squamous cell carcinoma cells. |
2009 |
Cancer Gene Ther. |
pmid:18949013
|
Zhou X et al. |
The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma. |
2007 |
Cancer Genet. Cytogenet. |
pmid:17693185
|
Mazzio EA and Soliman KFA |
Whole-transcriptomic Profile of SK-MEL-3 Melanoma Cells Treated with the Histone Deacetylase Inhibitor: Trichostatin A. |
|
Cancer Genomics Proteomics |
pmid:30194076
|
Mazzio EA and Soliman KF |
HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells. |
2017 |
Cancer Genomics Proteomics |
pmid:28031235
|
Shin S et al. |
Trichostatin A Sensitizes Hepatocellular Carcinoma Cells to Enhanced NK Cell-mediated Killing by Regulating Immune-related Genes. |
|
Cancer Genomics Proteomics |
pmid:28871002
|
Khan AN et al. |
An epigenetically altered tumor cell vaccine. |
2004 |
Cancer Immunol. Immunother. |
pmid:14997346
|
Khan AN et al. |
Histone deacetylase inhibitors induce TAP, LMP, Tapasin genes and MHC class I antigen presentation by melanoma cells. |
2008 |
Cancer Immunol. Immunother. |
pmid:18046553
|
Tiper IV and Webb TJ |
Histone deacetylase inhibitors enhance CD1d-dependent NKT cell responses to lymphoma. |
2016 |
Cancer Immunol. Immunother. |
pmid:27614429
|
Neumann F et al. |
EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors. |
2013 |
Cancer Immunol. Immunother. |
pmid:23619976
|
Meng CF et al. |
Role of histone modifications and DNA methylation in the regulation of O6-methylguanine-DNA methyltransferase gene expression in human stomach cancer cells. |
2010 |
Cancer Invest. |
pmid:19857042
|
Fang Y et al. |
Synergistic efficacy in human ovarian cancer cells by histone deacetylase inhibitor TSA and proteasome inhibitor PS-341. |
2011 |
Cancer Invest. |
pmid:21345073
|
Liu Y et al. |
Histone H3 (lys-9) deacetylation is associated with transcriptional silencing of E-cadherin in colorectal cancer cell lines. |
2008 |
Cancer Invest. |
pmid:18584348
|
Mousa SA et al. |
Stress resistant human embryonic stem cells as a potential source for the identification of novel cancer stem cell markers. |
2010 |
Cancer Lett. |
pmid:19733430
|
Sugimoto S et al. |
Expression and regulation of tumor suppressor gene maspin in human bladder cancer. |
2004 |
Cancer Lett. |
pmid:14732229
|
Li Y et al. |
Impairment of p53 acetylation by EWS-Fli1 chimeric protein in Ewing family tumors. |
2012 |
Cancer Lett. |
pmid:22266186
|
Jung EJ et al. |
Lytic induction and apoptosis of Epstein-Barr virus-associated gastric cancer cell line with epigenetic modifiers and ganciclovir. |
2007 |
Cancer Lett. |
pmid:16647201
|
Davies GF et al. |
Troglitazone inhibits histone deacetylase activity in breast cancer cells. |
2010 |
Cancer Lett. |
pmid:19699029
|
Hostetter CL et al. |
Timing is everything: order of administration of 5-aza 2' deoxycytidine, trichostatin A and tamoxifen changes estrogen receptor mRNA expression and cell sensitivity. |
2009 |
Cancer Lett. |
pmid:19013015
|
Francisco R et al. |
Histone deacetylase inhibition induces apoptosis and autophagy in human neuroblastoma cells. |
2012 |
Cancer Lett. |
pmid:22186300
|
Pitta CA et al. |
Reversal of ER-β silencing by chromatin modifying agents overrides acquired tamoxifen resistance. |
2013 |
Cancer Lett. |
pmid:23752064
|
Nair AR et al. |
Paradoxical effects of trichostatin A: inhibition of NF-Y-associated histone acetyltransferase activity, phosphorylation of hGCN5 and downregulation of cyclin A and B1 mRNA. |
2001 |
Cancer Lett. |
pmid:11295287
|
Zhang Q et al. |
Interferon regulatory factor 8 functions as a tumor suppressor in renal cell carcinoma and its promoter methylation is associated with patient poor prognosis. |
2014 |
Cancer Lett. |
pmid:25109451
|
Liu RF et al. |
Down-regulation of miR-517a and miR-517c promotes proliferation of hepatocellular carcinoma cells via targeting Pyk2. |
2013 |
Cancer Lett. |
pmid:23142219
|
Chen H et al. |
LTBP-2 confers pleiotropic suppression and promotes dormancy in a growth factor permissive microenvironment in nasopharyngeal carcinoma. |
2012 |
Cancer Lett. |
pmid:22743615
|
Januchowski R et al. |
Trichostatin A down-regulate DNA methyltransferase 1 in Jurkat T cells. |
2007 |
Cancer Lett. |
pmid:16624484
|
Koh E et al. |
Trichostatin A and 5-aza-2'-deoxycytidine switch S1P from an inhibitor to a stimulator of motility through epigenetic regulation of S1P receptors. |
2007 |
Cancer Lett. |
pmid:17189669
|
Bharadwaj S and Prasad GL |
Tropomyosin-1, a novel suppressor of cellular transformation is downregulated by promoter methylation in cancer cells. |
2002 |
Cancer Lett. |
pmid:12065096
|
Bazhin AV et al. |
Expression of GAGE family proteins in malignant melanoma. |
2007 |
Cancer Lett. |
pmid:17194529
|
Al-Rayyan N et al. |
5-Aza-2-deoxycytidine and trichostatin A increase COUP-TFII expression in antiestrogen-resistant breast cancer cell lines. |
2014 |
Cancer Lett. |
pmid:24513177
|
Chen Z et al. |
Induction and superinduction of growth arrest and DNA damage gene 45 (GADD45) alpha and beta messenger RNAs by histone deacetylase inhibitors trichostatin A (TSA) and butyrate in SW620 human colon carcinoma cells. |
2002 |
Cancer Lett. |
pmid:12406558
|
Gálfi P et al. |
Apoptosis sensitivity is not correlated with sensitivity to proliferation inhibition by the histone deacetylase inhibitors butyrate and TSA. |
2002 |
Cancer Lett. |
pmid:12406559
|
Ryu JK et al. |
SK-7041, a new histone deacetylase inhibitor, induces G2-M cell cycle arrest and apoptosis in pancreatic cancer cell lines. |
2006 |
Cancer Lett. |
pmid:16009488
|
Jung JW et al. |
Effects of the histone deacetylases inhibitors sodium butyrate and trichostatin A on the inhibition of gap junctional intercellular communication by H2O2- and 12-O-tetradecanoylphorbol-13-acetate in rat liver epithelial cells. |
2006 |
Cancer Lett. |
pmid:16337085
|
Ohike N et al. |
Clinicopathological significance and molecular regulation of maspin expression in ductal adenocarcinoma of the pancreas. |
2003 |
Cancer Lett. |
pmid:12969792
|
Hoebeeck J et al. |
Aberrant methylation of candidate tumor suppressor genes in neuroblastoma. |
2009 |
Cancer Lett. |
pmid:18819746
|
Bayart E et al. |
A major role for mitotic CDC2 kinase inactivation in the establishment of the mitotic DNA damage checkpoint. |
2004 |
Cancer Res. |
pmid:15604258
|
Yang X et al. |
Synergistic activation of functional estrogen receptor (ER)-alpha by DNA methyltransferase and histone deacetylase inhibition in human ER-alpha-negative breast cancer cells. |
2001 |
Cancer Res. |
pmid:11585728
|
Luo W et al. |
Epigenetic regulation of vitamin D 24-hydroxylase/CYP24A1 in human prostate cancer. |
2010 |
Cancer Res. |
pmid:20587525
|
Sasaki Y et al. |
p53 negatively regulates the hepatoma growth factor HDGF. |
2011 |
Cancer Res. |
pmid:22006999
|
Phan D et al. |
Identification of Sp2 as a transcriptional repressor of carcinoembryonic antigen-related cell adhesion molecule 1 in tumorigenesis. |
2004 |
Cancer Res. |
pmid:15126343
|
Wang X et al. |
Correction of the abnormal trafficking of primary myelofibrosis CD34+ cells by treatment with chromatin-modifying agents. |
2009 |
Cancer Res. |
pmid:19752087
|
Wei M et al. |
BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. |
2005 |
Cancer Res. |
pmid:16322213
|
Mariadason JM et al. |
Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. |
2000 |
Cancer Res. |
pmid:10969808
|
James SY et al. |
Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells. |
2003 |
Cancer Res. |
pmid:12839938
|
Terui T et al. |
Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors. |
2003 |
Cancer Res. |
pmid:14695212
|
Shah S et al. |
Targeting pioneering factor and hormone receptor cooperative pathways to suppress tumor progression. |
2012 |
Cancer Res. |
pmid:22258452
|
Sharma D et al. |
Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes. |
2006 |
Cancer Res. |
pmid:16778215
|
Shi J et al. |
Effects of chromatin-modifying agents on CD34+ cells from patients with idiopathic myelofibrosis. |
2007 |
Cancer Res. |
pmid:17616702
|
Su Y et al. |
Human RecQL4 helicase plays critical roles in prostate carcinogenesis. |
2010 |
Cancer Res. |
pmid:21045146
|
Qi H and Ratnam M |
Synergistic induction of folate receptor beta by all-trans retinoic acid and histone deacetylase inhibitors in acute myelogenous leukemia cells: mechanism and utility in enhancing selective growth inhibition by antifolates. |
2006 |
Cancer Res. |
pmid:16740727
|
Yoshida M et al. |
Effects of trichostatins on differentiation of murine erythroleukemia cells. |
1987 |
Cancer Res. |
pmid:2439196
|
Brest P et al. |
Histone deacetylase inhibitors promote the tumoricidal effect of HAMLET. |
2007 |
Cancer Res. |
pmid:18056459
|
Maecker HL et al. |
p53 promotes selection for Fas-mediated apoptotic resistance. |
2000 |
Cancer Res. |
pmid:10969818
|
Su GH et al. |
A novel histone deacetylase inhibitor identified by high-throughput transcriptional screening of a compound library. |
2000 |
Cancer Res. |
pmid:10866300
|
Blagosklonny MV et al. |
Depletion of mutant p53 and cytotoxicity of histone deacetylase inhibitors. |
2005 |
Cancer Res. |
pmid:16103091
|
Lin F et al. |
Unique anti-activator protein-1 activity of retinoic acid receptor beta. |
2000 |
Cancer Res. |
pmid:10866321
|
Hsu PY et al. |
Xenoestrogen-induced epigenetic repression of microRNA-9-3 in breast epithelial cells. |
2009 |
Cancer Res. |
pmid:19549897
|
Heller G et al. |
Genome-wide transcriptional response to 5-aza-2'-deoxycytidine and trichostatin a in multiple myeloma cells. |
2008 |
Cancer Res. |
pmid:18172295
|
Shin JY et al. |
Mechanism for inactivation of the KIP family cyclin-dependent kinase inhibitor genes in gastric cancer cells. |
2000 |
Cancer Res. |
pmid:10667572
|
Kretzner L et al. |
Combining histone deacetylase inhibitor vorinostat with aurora kinase inhibitors enhances lymphoma cell killing with repression of c-Myc, hTERT, and microRNA levels. |
2011 |
Cancer Res. |
pmid:21502403
|
Saunders N et al. |
Histone deacetylase inhibitors as potential anti-skin cancer agents. |
1999 |
Cancer Res. |
pmid:9927053
|
Ramsey MR et al. |
Physical association of HDAC1 and HDAC2 with p63 mediates transcriptional repression and tumor maintenance in squamous cell carcinoma. |
2011 |
Cancer Res. |
pmid:21527555
|
Medina V et al. |
Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A (inhibitors of histone deacetylase): dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway. |
1997 |
Cancer Res. |
pmid:9288776
|
Wilson AJ et al. |
Novel detection and differential utilization of a c-myc transcriptional block in colon cancer chemoprevention. |
2002 |
Cancer Res. |
pmid:12414619
|
Ho WC et al. |
Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. |
2005 |
Cancer Res. |
pmid:15899819
|
Tran T et al. |
Enhancement of folate receptor alpha expression in tumor cells through the glucocorticoid receptor: a promising means to improved tumor detection and targeting. |
2005 |
Cancer Res. |
pmid:15899836
|
Kim MS et al. |
Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. |
2003 |
Cancer Res. |
pmid:14612526
|
Majid S et al. |
Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer. |
2010 |
Cancer Res. |
pmid:20332239
|
Liu LT et al. |
Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. |
2003 |
Cancer Res. |
pmid:12810630
|
Allison SJ and Milner J |
Loss of p53 has site-specific effects on histone H3 modification, including serine 10 phosphorylation important for maintenance of ploidy. |
2003 |
Cancer Res. |
pmid:14583461
|
Sowa Y et al. |
Sp3, but not Sp1, mediates the transcriptional activation of the p21/WAF1/Cip1 gene promoter by histone deacetylase inhibitor. |
1999 |
Cancer Res. |
pmid:10485470
|
Lin YC et al. |
Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. |
2008 |
Cancer Res. |
pmid:18381445
|
Wang J et al. |
Inhibitors of histone deacetylase relieve ETO-mediated repression and induce differentiation of AML1-ETO leukemia cells. |
1999 |
Cancer Res. |
pmid:10383127
|
Myzak MC et al. |
A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. |
2004 |
Cancer Res. |
pmid:15313918
|
Kim TY et al. |
Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. |
2006 |
Cancer Res. |
pmid:16885346
|
Ferrara FF et al. |
Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia. |
2001 |
Cancer Res. |
pmid:11196162
|
Zhao S et al. |
Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. |
2003 |
Cancer Res. |
pmid:12750289
|
Bai J et al. |
Predominant Bcl-XL knockdown disables antiapoptotic mechanisms: tumor necrosis factor-related apoptosis-inducing ligand-based triple chemotherapy overcomes chemoresistance in pancreatic cancer cells in vitro. |
2005 |
Cancer Res. |
pmid:15781649
|
Yang X et al. |
Transcriptional activation of estrogen receptor alpha in human breast cancer cells by histone deacetylase inhibition. |
2000 |
Cancer Res. |
pmid:11156387
|
Rahmani M et al. |
Coadministration of histone deacetylase inhibitors and perifosine synergistically induces apoptosis in human leukemia cells through Akt and ERK1/2 inactivation and the generation of ceramide and reactive oxygen species. |
2005 |
Cancer Res. |
pmid:15781658
|
Stiehl DP et al. |
Histone deacetylase inhibitors synergize p300 autoacetylation that regulates its transactivation activity and complex formation. |
2007 |
Cancer Res. |
pmid:17332356
|
Kim M et al. |
LRRC3B, encoding a leucine-rich repeat-containing protein, is a putative tumor suppressor gene in gastric cancer. |
2008 |
Cancer Res. |
pmid:18757430
|
Mori T et al. |
Epigenetic up-regulation of C-C chemokine receptor 7 and C-X-C chemokine receptor 4 expression in melanoma cells. |
2005 |
Cancer Res. |
pmid:15753377
|
Zhu WG et al. |
DNA methyltransferase inhibition enhances apoptosis induced by histone deacetylase inhibitors. |
2001 |
Cancer Res. |
pmid:11245429
|
Pellicciotta I et al. |
Presentation of telomerase reverse transcriptase, a self-tumor antigen, is down-regulated by histone deacetylase inhibition. |
2008 |
Cancer Res. |
pmid:18829567
|